Ms.
NCATS, NIH
Madeleine Barrett is a graduate student in a joint doctoral program between the National Institutes of Health (National Center for Advancing Translational Sciences) and Karolinska Institutet in Stockholm, Sweden. She graduated with a B.S. in Biology from Oregon State University in 2018 and has experience in neural tract tracing, advanced imaging and precision oncology clinical trials. Her current project investigates novel small molecule inhibitors of glutathione peroxidase enzymes (GPx) as a potential cancer therapeutic. GPx enzymes are selenoprotein antioxidant enzymes which reduce hydroperoxides and are relied on heavily in some cancer types.